Research Center: Neuro Trials Victoria (NTVIC)
Location: 1 Beck Court, Noble Park, VIC 3174
Lead Doctor: Peter Farnbach MD
Ethics Committee: Bellberry Limited HREC

Background

Millions of people suffer from depression daily. Many people with depression find that antidepressants alone can’t adequately address all of their symptoms.

This study is evaluating an investigational drug designed to work in tandem with antidepressants to see if it might help improve unresolved symptoms of depression. The medication is a tablet that dissolves under the tongue.

This study seeks men and women between the ages of 18 & 70 who currently suffer from major depressive disorder for more than 8 weeks, but less than 5 years. Participants will be randomised and will receive either the experimental drug or the placebo, there is a 50 percent chance that a participant will receive either the experimental drug or placebo. Participants are required to attend 14 to 20 study visits at the research site over a 5 month period, and could experience an improvement in depression symptoms.

Benefits of Participation

• You could experience an improvement in your depression symptoms.
• You will be helping to advance medical research.
• You will be given the study drug free of charge

Your Rights

• If you decide to participate in the study and later feel that you no longer wish to be part of it, you may withdraw at any time.
• Your records relating to this study and any other information received will be kept strictly confidential, except as required by the law.
• Qualified health professionals will monitor your health as it relates to the study.

Who Can Participate?

• Men and women aged 18 to 70 who suffer from major depressive disorder.
• Able to attend 14 to 20 study visits at the research site over approximately 5 months